Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C3orf49, or Chromosome 3 open reading frame 49, is a protein-coding gene described as a putative uncharacterized protein due to the lack of known molecular function or biological activity in humans[3]. No strong evidence links it to established molecular classifications such as receptors, enzymes, ion channels, or transcription factors[3][6]. While there is a nominal genetic association between C3orf49 and Spinocerebellar Ataxia 36, direct functional or mechanistic roles have not been elucidated[3]. There are currently no known drugs that target C3orf49, and no utility has been described for it as a biomarker for therapy or disease monitoring[3][6]. C3orf49 should not be considered a validated therapeutic target or molecular receptor at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 3 open reading frame 49 (C3orf49).